• Home
  • About Us
  • Science
    • ImmunoBody®
    • Moditope®
    • Glymab®
    • Publications
  • Pipeline
  • News
  • Investors
    • Share Info
    • Financial Info
    • Documents & Presentations
    • Corporate Governance
  • Contact Us
    • Find a trial
    • Become an Investigator

Scancell Appoints Dr Nermeen Varawalla as Chief Medical Officer

by admin | Aug 22, 2024

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

Scancell Appoints Dr Nermeen Varawalla as Chief Medical Officer

by admin | Aug 22, 2024

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

Scancell Appoints Dr Nermeen Varawalla as Chief Medical Officer

by admin | Aug 22, 2024

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

Scancell Appoints Dr Nermeen Varawalla as Chief Medical Officer

by admin | Aug 22, 2024

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

Scancell Appoints Dr Nermeen Varawalla as Chief Medical Officer

by admin | Aug 22, 2024

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
« Older Entries

Recent Posts

  • iSCIB1+ pivotal trial plans advancing
  • AACR (American Association for Cancer Research) Annual Meeting, April 2026, San Diego, California
  • Scancell Receives FDA Fast Track Designation for iSCIB1+
  • Scancell announces CFO Transition
  • Edison Report – Redesigning immunity: The next frontier in immuno-oncology

Recent Comments

No comments to show.

Scancell is focused on developing novel immunotherapies for the treatment of cancer and was founded in 1996 based on research led by Professor Lindy Durrant at the University of Nottingham in the UK.

  • Follow
  • Follow

About Us
Leadership Team
Science
Our Pipeline
News
Contact Us
Find a Trial
Become an Investigator

ACTIVE IMMUNOTHERAPY

ImmunoBody®
Moditope®

ANTIBODIES

GlyMab®
AvidiMab®

Investors
Company Profile
Advisors
Corporate Governance
Documents & Presentations
Share Information
Financial Information

Copyright © 2026 Scancell | Website Designed & Developed by Identity Creative | Privacy & Cookie Policy